Experts look at trends in antibody drug development, including the growing popularity of new modalities.

Stakeholders explain why the NIH’s move to cap indirect costs associated with research grants could damage medical innovation.

Why you shouldn’t neglect the importance of blending people, culture, and strategy to foster success in a business.

How snake venom, genomic data, and deep learning computation methods have combined to bring new advances in drug discovery.

Review shows that antidepressants have significant effect when treating generalized anxiety disorder.

How the right partnerships are helping streamline CGT manufacturing through robotics and digital tools.

Study investigates why vial choices matters for frozen biopharmaceutical storage.

US-based pharmaceutical associations fear the supply chain repercussions of tariffs, and offer advice for a more sustainable alternative.

So much has already been achieved with RNA – and it’s only going to get better.

We speak with Sanofi’s Anju Bhalla about its appeal against NICE’s final draft guidance for Sarclisa.